Searching journal content for endocrine resistance (as phrase) in full text.

Displaying results 1-10 of 95
For checked items
  1. Commentary:
    • Giorgio Secreto,
    • Paola Muti,
    • Milena Sant,
    • Elisabetta Meneghini,
    • and Vittorio Krogh
    Medical ovariectomy in menopausal breast cancer patients with high testosterone levels: a further step toward tailored therapy Endocr Relat Cancer 24 (11) C21-C29, doi:10.1530/ERC-17-0251 first published on 16 August 2017
    ...endocrine resistance suggesting the involvement of androgens as activators of the androgen receptor pathway and as stimulators of epidermal growth factor synthesis and function. Data from a series of prospective studies on operable breast cancer patients, showing high serum testosterone levels are a ~~~
  2. Review:
    • Andrew M K Law,
    • Elgene Lim,
    • Christopher J Ormandy,
    • and David Gallego-Ortega
    The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy Endocr Relat Cancer 24 (4) R123-R144, doi:10.1530/ERC-16-0404 first published on 13 February 2017
    ...endocrine resistance are necessary, as cell lines and xenografts in immunodeficient R128Review A M K Law et al. Immunotherapy in breast cancer DOI: 10.1530/ERC-16-0404 http://.endocrinology-journals.org © 2017 The authors Printed in Great Britain Published by Bioscientifica Ltd. 24:4 mice are unable ~~~
    OPEN ACCESS ARTICLE
  3. Review:
    • Tesa M Severson and
    • Wilbert Zwart
    A review of estrogen receptor/androgen receptor genomics in male breast cancer Endocr Relat Cancer 24 (3) R27-R34, doi:10.1530/ERC-16-0225 first published on 6 January 2017
    ...endocrine resistance at an early stage, so that patients with a predicted resistance can be treated with an alternative treatment instead. ERα and AR both have thousands of known DNA-binding sites in breast and prostate cancer, respectively ( Carroll et al. 2006 , Chng et al. 2012 , Jansen et al. 20 ~~~
  4. Thematic Review:
    • Elgene Lim,
    • Gerard Tarulli,
    • Neil Portman,
    • Theresa E Hickey,
    • Wayne D Tilley,
    • and Carlo Palmieri
    Pushing estrogen receptor around in breast cancer Endocr Relat Cancer 23 (12) T227-T241, doi:10.1530/ERC-16-0427 first published on 11 October 2016
    ...endocrine resistance f breast cancer f progesterone receptor f androgen receptor T228Thematic Review E Lim et al. Pushing ER around in breast cancer DOI: 10.1530/ERC-16-0427 http://.endocrinology-journals.org © 2016 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. ~~~
  5. Thematic Review:
    • John W Cassidy,
    • Ankita S Batra,
    • Wendy Greenwood,
    • and Alejandra Bruna
    Patient-derived tumour xenografts for breast cancer drug discovery Endocr Relat Cancer 23 (12) T259-T270, doi:10.1530/ERC-16-0251 first published on 4 October 2016
    ...endocrine resistance in breast cancer. Cancer Research 73 6856–6864. (doi:10.1158/0008-5472) Mestas J & Hughes CCW 2004 Of mice and not men: differences between mouse and human immunology. Journal of Immunology 172 2731–2738. (doi:10.4049/jimmunol.172.5.2731) Miller CA, Gindin Y, Lu C, Griffith OL, ~~~
    OPEN ACCESS ARTICLE
  6. Review:
    • Aleksandra M Ochnik and
    • Robert C Baxter
    Combination therapy approaches to target insulin-like growth factor receptor signaling in breast cancer Endocr Relat Cancer 23 (11) R527-R550, doi:10.1530/ERC-16-0218
    ...endocrine resistance in breast cancer. Nature Reviews Clinical Oncology 12 573–583. (doi:10.1038/nrclinonc.2015.117) Ji QS, Mulvihill MJ, Rosenfeld-Franklin M, Cooke A, Feng L, Mak G, O’Connor M, Yao Y, Pirritt C, Buck E, et al. 2007 A novel, potent, and selective insulin-like growth factor-I recept ~~~
  7. Research:
    • Allison Sumis,
    • Katherine L Cook,
    • Fabia O Andrade,
    • Rong Hu,
    • Emma Kidney,
    • Xiyuan Zhang,
    • Dominic Kim,
    • Elissa Carney,
    • Nguyen Nguyen,
    • Wei Yu,
    • Kerrie B Bouker,
    • Idalia Cruz,
    • Robert Clarke,
    • and Leena Hilakivi-Clarke
    Social isolation induces autophagy in the mouse mammary gland: link to increased mammary cancer risk Endocr Relat Cancer 23 (10) 839-856, doi:10.1530/ERC-16-0359 first published on 22 August 2016
    ...endocrine resistance in breast cancer. Expert Review of Anticancer Therapy 11 1283–1294. (doi:10.1586/era.11.111) Costa V, Foti D, Paonessa F, Chiefari E, Palaia L, Brunetti G, Gulletta E, Fusco A & Brunetti A 2008 The insulin receptor: a new anticancer target for peroxisome proliferator-activated r ~~~
  8. Review:
    • Conleth G Murphy and
    • Maura N Dickler
    Endocrine resistance in hormone-responsive breast cancer: mechanisms and therapeutic strategies Endocr Relat Cancer 23 (8) R337-R352, doi:10.1530/ERC-16-0121 first published on 12 July 2016
    ...endocrine resistance and to develop treatment strategies that utilize this understanding to Endocrine-Related Cancer (2016) 23, R337–R352 238 R337–R352 Key Words f endocrine therapy f endocrine therapy resistance f breast cancer Correspondence should be addressed to M N Dickler Email dicklerm@mskcc. ~~~
  9. Review:
    • M Bullock
    FOXO factors and breast cancer: outfoxing endocrine resistance Endocr Relat Cancer 23 (2) R113-R130, doi:10.1530/ERC-15-0461 first published on 26 November 2015
    ...endocrine resistance 23 :2 R113–R130function. Although breast cancer cells express multiplecancer growth, including altered estrogen receptor (ER) human with 43 members (Katoh & Katoh 2004). These proteins are characterized solely by the presence of asignaling (Zhang et al. 2011, Fig. 1). It is also ~~~
  10. Thematic Review:
    • Bruno M Simões,
    • Denis G Alferez,
    • Sacha J Howell,
    • and Robert B Clarke
    The role of steroid hormones in breast cancer stem cells Endocr Relat Cancer 22 (6) T177-T186, doi:10.1530/ERC-15-0350 first published on 17 September 2015
    ...endocrine resistance compromises this otherwise effective treatment and thus the potential cure of ERC breast cancers. Therefore, defining the mechanisms of endocrine resistance is a major research focus. Activation of classical signalling pathways, including the ones induced by HER2 and EGF recepto ~~~
For checked items

Search Results

Next 10 » New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most